Learn More
Medchemexpress LLC D18 | 2230218-36-5 | 98.8% | C21H28N6 | 1 MG

Supplier: Medchemexpress LLC HY1445011MG
D18 is an immune modulator and acts as a TLR7/8 dual agonist. It increases PD-L1 expression through epigenetic regulation, sensitizing tumors to PD-1/PD-L1 blockade. This substance is also an ADC cytotoxin used for the synthesis of ADC HE-S2 (HY-144497) and exhibits strong immune activation and anti-tumor activity, commonly used in cancer research.
- Acts as a TLR7/8 dual agonist
- Increases PD-L1 expression through epigenetic regulation
- Sensitizes tumors to PD-1/PD-L1 blockade
- Utilized as an ADC cytotoxin for ADC HE-S2 synthesis
- Exhibits strong immune activation and anti-tumor activity
- Used in cancer research, including colon cancer
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.